13 Jul 2023
12 Jul 2023
“Accomplishing this work will enable the design of intervention & perhaps prevention for patients with myeloid malignancies.” -Dr. Britta Will, an LLS-funded researcher, & her lab are doing innovative work uncovering treatment for myeloid malignancies 🔬👉 bit.ly/3rtGToi
1
1
14
5,414
10 Jul 2023
Since 1992, the Career Development Program #LLSCDP has been providing support to promising early-career scientists.
The 2023-2024 application cycle is open right now!!
👉rb.gy/t0q43
Please share!
2
4
534
24 Aug 2022
Congratulations to @AbdelWahablab our 2021 #LLSCDP #LLSCSCR Achievement Award recipient!
“I cannot thank LLS enough for how much they have done for myself, my trainees, and blood cancer patients." @MSKCancerCenter @LLSusa
👉bit.ly/3PH6WyY
2
9
24 Aug 2022
The #LLSCDP Achievement Awards acknowledge the most impressive Scholar or Scholar in Clinical Research, Special Fellow & Fellow
Please join us & congratulate our 2021 winners: the best of the best! @AbdelWahablab, Dr. Courtney Jones and @lindemilesphd
👉bit.ly/3TexvOZ
8
7
49
27 Sep 2021
The members of the Majeti lab are proud of our boss, @RaviMajetiMD, for receiving the 2020 #LLSCDP Scholar Achievement Award!
Congratulations also to LLSCDP Achievement Awardees @dstarczynowski, @Akihide_Yoshimi, and @DrMattWit! Well deserved recognition of their amazing work!
24 Sep 2021
The #LLSCDP Achievement Awards acknowledge the most impressive Scholar or Scholar in Clinical Research, Special Fellow & Fellow
Please join us & congratulate our 2020 winners: the best of the best! @majetilab @dstarczynowski @Akihide_Yoshimi @DrMattWit
👉bit.ly/3CJD5jj
3
2
47
25 Sep 2021
Congratulations to @majetilab @Akihide_Yoshimi @DrMattWit for being selected for the @LLSCDP Achievement Award! I am honored and humbled to be among this amazing group of recipients! Grateful to my collaborators and lab members and for the support of @LLSResearch
13
【受賞】がんRNA研究ユニット@YoshimiLab の吉見昭秀さん@Akihide_Yoshimi が、Leukemia & Lymphoma Society @LLSusa #LLSCDP Achievement Awardに選ばれました！
研究室紹介➡️ bit.ly/3i5oqXS
24 Sep 2021
The #LLSCDP Achievement Awards acknowledge the most impressive Scholar or Scholar in Clinical Research, Special Fellow & Fellow
Please join us & congratulate our 2020 winners: the best of the best! @majetilab @dstarczynowski @Akihide_Yoshimi @DrMattWit
👉bit.ly/3CJD5jj
3
6
[Award] Congratulations @Akihide_Yoshimi from @YoshimiLab on winning the #LLSCDP Achievement Award!
Thank you @LLSusa for the support!
24 Sep 2021
The #LLSCDP Achievement Awards acknowledge the most impressive Scholar or Scholar in Clinical Research, Special Fellow & Fellow
Please join us & congratulate our 2020 winners: the best of the best! @majetilab @dstarczynowski @Akihide_Yoshimi @DrMattWit
👉bit.ly/3CJD5jj
3
5
24 Sep 2021
The #LLSCDP Achievement Awards acknowledge the most impressive Scholar or Scholar in Clinical Research, Special Fellow & Fellow
Please join us & congratulate our 2020 winners: the best of the best! @majetilab @dstarczynowski @Akihide_Yoshimi @DrMattWit
👉bit.ly/3CJD5jj
6
4
35
7 Sep 2021
Are you an early-stage #bloodcancer scientist or physician-scientist?
Our Career Development Program #LLSCDP @LLSusa is designed to support promising young investigators and it is currently OPEN!
Follow the link for details and instructions 👉bit.ly/3BQZg6y
4
11 May 2020
Congratulations to the recently elected members of @theNASciences, especially our #LLSCDP #LLSSCOR #LLSTRP grantees: @carlhjune @PennMedicine, @Spo11Rulz @sloan_kettering, Dr. Judy Lieberman @BostonChildrens, Dr. Lorraine S. Symington @ColumbiaMed! 👏👏👏
bit.ly/2yNgdE3
3
21 Apr 2020
Congratulations @Dr_AmerZeidan #LLSCDP #LLSScr in Clinical Research and team on his new study in @BloodAdvances on the high mortality/morbidity and resources required for older #AML patients upon first round of traditional chemo treatment.
21 Apr 2020
Our latest paper showing high morbidity, mortality and resource use during first admission for induction chemotherapy for AML in USA-16% died or were discharged to hospice (24% for ≥65 years). We need more tolerated therapies especially for older patients
1
2
23 Mar 2020
Congratulations to @landau_lab #LLSTRP, @AbdelWahablab #LLSCDP #LLS and team on their new work out in @NatureGenet today!!!
23 Mar 2020
Curious how do DNA methylation modifier mutations shape blood differentiation topographies?
Check out our new work @NatureGenet: nature.com/articles/s41588-0…
#SingleCells #MultiOmics #ClonalHematopoiesis
1
12
19 Mar 2020
New publication alert in @BloodAdvances from @majetilab #LLSCDP #LLSSCR investigating #AML #MRD with targeted single-cell sequencing
18 Mar 2020
Summary of our newest publication in Blood Advances: SCS can provide information on mutation co-occurrence and leukemia heterogeneity which is informative in evaluating MRD; this data shows early potential in the clinical utility for this application.
1
2
17 Mar 2020
New publication alert! #LLSCDP #LLSNIA grantees @lane_andy @vangalenlab and team in @NatureComms. See Dr. Lane's twittorial walking us through the story of how master transcriptome/epigenome regulators are mutated in AML and their global effects.
16 Mar 2020
Chromatin accessibility promotes hematopoietic and leukemia stem cell activity | @NatureComms . Direct link to our new paper here and short story follows. 1/n
nature.com/articles/s41467-0…
9
6 Feb 2020
Meet one of our #LLSCDP awardees, Dr. Omar Abdel-Wahab of @AbdelWahablab @sloan_kettering and read about his exciting work in blood cancer: tinyurl.com/s2un83g
2
22
11 Dec 2019
Congratulations to @vangalenlab: our 2019 #LLSFellow Achievement Award recipient!
“Being awarded the #LLSCDP Award from the @LLSusa has been transformative for my postdoctoral work and early career. All these aspects jump started my career at a critical stage" @HarvardMed #ASH19
3
40
11 Dec 2019
Congratulations to Dr. Shannon Elf our 2019 #LLSCDP #LLSSFellow Achievement Award recipient!
“CDP has been a critical component of my transitioning to this independent position and kickstarting the projects currently ongoing in my independent laboratory.”
@UChicago @LLSusa #ASH19
2
23
21 Aug 2019
Inrebic approved as treatment for #myelofibrosis!
#LLSResearch helped advance this drug through supporting several preclinical studies #LLSCDP #LLSTRP #LLSSCOR starting from 2006, showing that our strategic research investment in early studies is important and will pay off!
16 Aug 2019
Today FDA approved fedratinib for adults with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. Further info for hc providers: go.usa.gov/xVCNA
1
4